Tirzepatide 60mg
High-resolution product image coming soon
Research & Studies
Certificate of Analysis & scientific papers will appear here
GLP-1 & Weight Loss
Tirzepatide 60mg
60mg
Dual GLP-1/GIP receptor agonist promoting weight loss, improved glucose metabolism, and enhanced insulin sensitivity. Reduces appetite and food cravings. Side Effects: Nausea, vomiting, diarrhea, constipation, injection site reactions. Generally mild and diminish over time. Usage: Subcutaneous injection once weekly. Typical dosing starts at 2.5mg and titrates based on response.
Email us to place an order and create an account.
Lab Tested
99%+ purity
Secure Order
SSL encrypted
Discreet Ship
Plain packaging
Research Purposes Only. This product is intended for in-vitro research and laboratory use only. Not for human consumption. Not for veterinary use. Must be handled by qualified research personnel. Keep out of reach of children.